Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Elucidation of the Mechanism of IVIG-Associated Hemolysis

NCT02259478 is registered in ClinicalTrials.gov with Toronto Transfusion Medicine Collaborative as lead sponsor.

NCT NCT02259478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02259478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Elucidation of the Mechanism of IVIG-Associated Hemolysis
Lead sponsor
Toronto Transfusion Medicine Collaborative
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
December 31, 2016
Enrollment
144 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hemolysis, immunoglobulins, intravenous